FDA
Carbidopa and Levodopa
The FDA lists this product in 14 strengths and forms.
Composition
- Active ingredients
- CARBIDOPA, LEVODOPA 210MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CARBIDOPA, LEVODOPA 195MG · Capsule, extended releaseANDA219231-008 · Tentative approval
- CARBIDOPA, LEVODOPA 61.25MG · Capsule, extended releaseANDA219231-006 · Tentative approval
- CARBIDOPA, LEVODOPA 95MG · Capsule, extended releaseANDA219231-004 · Tentative approval
- CARBIDOPA, LEVODOPA 145MG · Capsule, extended releaseANDA219231-002 · Tentative approval
- CARBIDOPA, LEVODOPA 48.75MG · Capsule, extended releaseANDA219231-007 · Tentative approval
- CARBIDOPA, LEVODOPA 245MG · Capsule, extended releaseANDA219231-005 · Tentative approval
- CARBIDOPA, LEVODOPA 23.75 · Capsule, extended releaseANDA219231-003 · Tentative approval
- CARBIDOPA, LEVODOPA 52.5MG · Capsule, extended releaseANDA219989-007 · Tentative approval
- CARBIDOPA, LEVODOPA 70MG · Capsule, extended releaseANDA219989-005 · Tentative approval
- CARBIDOPA, LEVODOPA 87.5MG · Capsule, extended releaseANDA219989-003 · Tentative approval
At a glance
- Brand name
- Carbidopa and Levodopa
- Active substance
- carbidopa, levodopa
- Dosage form
- Capsule, extended release
- Applicant
- Sandoz Inc
- Status
- Tentative approval
- FDA approval
- 12 Nov 2025
- Application
- ANDA219989-008